Great to read, mr f6.
One fly in the ointment ... looks like the $20 million isn't there. Why else would the deal be rewritten
at the last minute, to excuse any obligation to raise the $20 million? Management has been seen
overseas trying to raise the money, having apparently failed to fill the deal in Oz, and word on the
ground is that it isn't going well at all. So ittle or no cash, is what I'm hearing.
Latest "Management" Circular Core/Titan on Sedar.com, page 43. The commitment to $20 million
evaporated. There is no commitment to raise the funds anymore, at the discretion of Core/Titan.
Plus, with dissenting shareholders, they have to pay millions, out of the box. Plus they have all
kinds of marketing/inducements/legal to pay now, which may likely be millions too. Sounds like zero
cash.
So that leaves a merged company .. with maybe no cash. Doesn't that bring things back to
square one?
What's your opinion?
- Forums
- ASX - By Stock
- Ann: Core Gold Circular and Proposed CEO MD
Great to read, mr f6.One fly in the ointment ... looks like the...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TTM (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.005(11.1%) |
Mkt cap ! $91.38M |
Open | High | Low | Value | Volume |
4.5¢ | 5.0¢ | 4.5¢ | $224.5K | 4.625M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 296918 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 140000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 296918 | 0.050 |
1 | 310000 | 0.047 |
1 | 133266 | 0.045 |
1 | 75000 | 0.041 |
3 | 290000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 140000 | 2 |
0.052 | 800000 | 2 |
0.053 | 170000 | 1 |
0.054 | 330000 | 1 |
0.055 | 100000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
TTM (ASX) Chart |